The biological significance of lymphangiogenesis in human tumours

Diagnostic Histopathology

Volumn 16, Issue 6, 2010, Pages 295-305

  Massi, Daniela ^a,b   Gököz, Özay ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

cancer; lymph nodes; lymphangiogenesis; lymphatic endothelial cells; lymphatic vessels; metastasis; VEGF C; VEGF D; VEGFR 3

Indexed keywords

5' NUCLEOTIDASE; AQUAPORIN 1; BIOLOGICAL MARKER; DECOY CHEMOKINE RECEPTOR; DESMOPLAKIN; MACROPHAGE MANNOSE RECEPTOR 1; NEUROPILIN 2; PODOPLANIN; PROTEIN B27; PROTEIN LA102; PROTEIN LYP 1; PROTEIN LYVE 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RELAPSE; CANCER SURVIVAL; COLORECTAL CANCER; DENSITY; ENDOTHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LARYNX CARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL DENSITY; LYMPHANGIOGENESIS; MELANOMA; METASTASIS POTENTIAL; MOLECULAR MECHANICS; MOUTH CARCINOMA; NONHUMAN; OVARY TUMOR; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TONGUE CARCINOMA; TREATMENT INDICATION; TUMOR; TUMOR DIFFERENTIATION; TUMOR GROWTH; URINARY TRACT CARCINOMA; UTERINE CERVIX CANCER;

EID: 77952674977     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2010.03.011     Document Type: Article

References (87)

1. Schmid-Schonbein G.W. Microlymphatics and lymph flow. Physiol Rev 70 (1990) 987-1028
2. Karkkainen M.J., Haiko P., Sainio K., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5 (2004) 74-80
3. Wigle J.T., and Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999) 769-778
4. Oliver G. Lymphatic vasculature development. Nat Rev Immunol 4 (2004) 35-45
5. Liersch R., and Detmar M. Lymphangiogenesis in development and disease. Thromb Haemost 98 (2007) 304-310
6. Petrova T.V., Makinen T., Makela T.P., et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21 (2002) 4593-4599
7. Shin J.W., Min M., Larrieu-Lahargue F., et al. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17 (2006) 576-584
8. Dumont D.J., Jussila L., Taipale J., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282 (1998) 946-949
9. Partanen T.A., Arola J., Saaristo A., et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14 (2000) 2087-2096
10. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., and Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156 (2000) 1499-1504
11. Makinen T., Adams R.H., Bailey J., et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19 (2005) 397-410
12. Brantley-Sieders D.M., Fang W.B., Hwang Y., Hicks D., and Chen J. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Cancer Res 66 (2006) 10315-10324
13. Hogan B.M., Bos F.L., Bussmann J., et al. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41 (2009) 396-398
14. Cao Y., and Zhong W. Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother 61 (2007) 534-539
15. Sundar S.S., and Ganesan T.S. Role of lymphangiogenesis in cancer. J Clin Oncol 25 (2007) 4298-4307
16. Bjorndahl M.A., Cao R., Burton J.B., et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65 (2005) 9261-9268
17. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
18. Kajiya K., Hirakawa S., Ma B., Drinnenberg I., and Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 24 (2005) 2885-2895
19. Spinella F., Garrafa E., Di Castro V., et al. Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. Cancer Res 69 (2009) 2669-2676
20. Baluk P., and McDonald D.M. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 1131 (2008) 1-12
21. Cueni L.N., and Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 126 (2006) 2167-2177
22. Sleeman J.P., and Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer (2009 Jun 30) [Epub ahead of print]
23. Leu A.J., Berk D.A., Lymboussaki A., Alitalo K., and Jain R.K. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60 (2000) 4324-4327
24. Schoppmann S.F., Birner P., Stockl J., et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161 (2002) 947-956
25. Ji R.C. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev 25 (2006) 677-694
26. Mashino K., Sadanaga N., Yamaguchi H., et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62 (2002) 2937-2941
27. Shields J.D., Emmett M.S., Dunn D.B., et al. Chemokine-mediated migration of melanoma cells towards lymphatics - a mechanism contributing to metastasis. Oncogene 26 (2007) 2997-3005
28. Ohhashi T., Mizuno R., Ikomi F., and Kawai Y. Current topics of physiology and pharmacology in the lymphatic system. Pharmacol Ther 105 (2005) 165-188
29. Nakamura Y., Yasuoka H., Zuo H., et al. Nitric oxide in papillary thyroid carcinoma: induction of vascular endothelial growth factor D and correlation with lymph node metastasis. J Clin Endocrinol Metab 91 (2006) 1582-1585
30. Massi D., De Nisi M.C., Franchi A., et al. Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis. Mod Pathol 22 (2009) 21-30
31. Fukumura D., Kashiwagi S., and Jain R.K. The role of nitric oxide in tumour progression. Nat Rev Cancer 6 (2006) 521-534
32. Kajiya K., Huggenberger R., Drinnenberg I., Ma B., and Detmar M. Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation. FASEB J 22 (2008) 530-537
33. Lahdenranta J., Hagendoorn J., Padera T.P., et al. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis. Cancer Res 69 (2009) 2801-2808
34. Maula S.M., Luukkaa M., Grenman R., Jackson D., Jalkanen S., and Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63 (2003) 1920-1926
35. Kyzas P.A., Geleff S., Batistatou A., Agnantis N.J., and Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206 (2005) 170-177
36. Frech S., Hormann K., Riedel F., and Gotte K. Lymphatic vessel density in correlation to lymph node metastasis in head and neck squamous cell carcinoma. Anticancer Res 29 (2009) 1675-1679
37. Baek S.K., Jung K.Y., Lee S.H., et al. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma. Laryngoscope 119 (2009) 1325-1330
38. Chung M.K., Min J.Y., So Y.K., et al. Correlation between lymphatic vessel density and regional metastasis in squamous cell carcinoma of the tongue. Head Neck (2009 Aug 11) [Epub ahead of print]
39. Sugiura T., Inoue Y., Matsuki R., et al. VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Int J Oncol 34 (2009) 673-680
40. Audet N., Beasley N.J., MacMillan C., Jackson D.G., Gullane P.J., and Kamel-Reid S. Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 131 (2005) 1065-1070
41. Franchi A., Massi D., Santucci M., et al. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J Pathol 208 (2006) 439-445
42. Dadras S.S., Lange-Asschenfeldt B., Velasco P., et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18 (2005) 1232-1242
43. Dadras S.S., Paul T., Bertoncini J., et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162 (2003) 1951-1960
44. Massi D., Puig S., Franchi A., et al. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol 59 (2006) 166-173
45. Shields J.D., Borsetti M., Rigby H., et al. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 90 (2004) 693-700
46. Valencak J., Heere-Ress E., Kopp T., Schoppmann S.F., Kittler H., and Pehamberger H. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 40 (2004) 358-364
47. Straume O., Jackson D.G., and Akslen L.A. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9 (2003) 250-256
48. Sun J.G., Wang Y., Chen Z.T., et al. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value. J Exp Clin Cancer Res 28 (2009) 21
49. Kadota K., Huang C.L., Liu D., et al. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer 44 (2008) 1057-1067
50. Renyi-Vamos F., Tovari J., Fillinger J., et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 11 (2005) 7344-7353
51. Iwakiri S., Nagai S., Katakura H., et al. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung. Ann Surg Oncol 16 (2009) 1678-1685
52. Thelen A., Jonas S., Benckert C., et al. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma. Ann Surg Oncol 16 (2009) 1222-1230
53. Kadowaki I., Ichinohasama R., Harigae H., et al. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol 130 (2005) 869-877
54. Agarwal B., Saxena R., Morimiya A., Mehrotra S., and Badve S. Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 29 (2005) 1449-1455
55. Vleugel M.M., Bos R., van der Groep P., et al. Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol 57 (2004) 746-751
56. Williams C.S., Leek R.D., Robson A.M., et al. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 200 (2003) 195-206
57. Bono P., Wasenius V.M., Heikkila P., Lundin J., Jackson D.G., and Joensuu H. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 10 (2004) 7144-7149
58. Nakamura Y., Yasuoka H., Tsujimoto M., et al. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 91 (2005) 125-132
59. Gu Y., Qi X., and Guo S. Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. Clin Exp Metastasis 25 (2008) 717-725
60. Mohammed R.A., Ellis I.O., Elsheikh S., Paish E.C., and Martin S.G. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications. Breast Cancer Res Treat 113 (2009) 261-273
61. Royston D., and Jackson D.G. Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 217 (2009) 608-619
62. Yan G., Zhou X.Y., Cai S.J., Zhang G.H., Peng J.J., and Du X. Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World J Gastroenterol 14 (2008) 101-107
63. Gao J., Knutsen A., Arbman G., Carstensen J., Franlund B., and Sun X.F. Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis 41 (2009) 116-122
64. Longatto-Filho A., Pinheiro C., Ferreira L., et al. Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Archiv 452 (2008) 133-138
65. Birner P., Schindl M., Obermair A., Breitenecker G., Kowalski H., and Oberhuber G. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 95 (2001) 29-33
66. Zhang S.Q., Yu H., and Zhang L.L. Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method study. BMC Cancer 9 (2009) 64
67. Yu H., Zhang S., Zhang R., and Zhang L. The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma. J Exp Clin Cancer Res 28 (2009) 98
68. Bolenz C., Fernandez M.I., Trojan L., et al. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int 103 (2009) 1040-1046
69. Kuroda K., Horiguchi A., Asano T., and Hayakawa M. Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores. Prostate 68 (2008) 1057-1063
70. Cheng L., Bishop E., Zhou H., et al. Lymphatic vessel density in radical prostatectomy specimens. Hum Pathol 39 (2008) 610-615
71. Trojan L., Michel M.S., Rensch F., Jackson D.G., Alken P., and Grobholz R. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol 172 (2004) 103-107
72. Fadare O., Orejudos M.P., Jain R., et al. A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignant potential (borderline tumors) with and without lymph node involvement. Int J Gynecol Pathol 27 (2008) 483-490
73. Inoue A., Moriya H., Katada N., et al. Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int 58 (2008) 611-619
74. Saad R.S., Lindner J.L., Liu Y., and Silverman J.F. Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma. Am J Clin Pathol 131 (2009) 92-98
75. Nakamura Y., Yasuoka H., Tsujimoto M., et al. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer. J Clin Pathol 59 (2006) 77-82
76. Gao P., Zhou G.Y., Zhang Q.H., et al. Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma. Cancer Lett 263 (2008) 223-230
77. Coskun U., Akyurek N., Dursun A., and Yamac D. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. J Surg Res (2009 May 3) [Epub ahead of print]
78. Gao P., Zhou G.Y., Zhang Q.H., et al. Lymphangiogenesis in gastric carcinoma correlates with prognosis. J Pathol 218 (2009) 192-200
79. Van der Auwera I., Cao Y., Tille J.C., et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 95 (2006) 1611-1625
80. Das S., and Skobe M. Lymphatic vessel activation in cancer. Ann N Y Acad Sci 1131 (2008) 235-241
81. Achen M.G., Mann G.B., and Stacker S.A. Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 94 (2006) 1355-1360
82. Ji R.C. Lymph node lymphangiogenesis: a new concept for modulating tumor metastasis and inflammatory process. Histol Histopathol 24 (2009) 377-384
83. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., and Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109 (2007) 1010-1017
84. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L.F., and Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201 (2005) 1089-1099
85. Van den Eynden G.G., Vandenberghe M.K., van Dam P.J., et al. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res 13 (2007) 5391-5397
86. Hirakawa S. From tumor lymphangiogenesis to lymphvascular niche. Cancer Sci 100 (2009) 983-989
87. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56